|
SAVA
|
Cassava Sciences, Inc.
|
2.10%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
2.07%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
1.95%
|
US
|
NASDAQ
|
|
ACHC
|
Acadia Healthcare Company, Inc.
|
1.69%
|
US
|
NASDAQ
|
|
VRDN
|
Viridian Therapeutics, Inc.
|
1.55%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
1.51%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
1.47%
|
US
|
NASDAQ
|
|
MDRX
|
Allscripts Healthcare Solutions, Inc.
|
1.36%
|
US
|
NASDAQ
|
|
MMSI
|
Merit Medical Systems, Inc.
|
1.35%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
1.23%
|
US
|
NASDAQ
|
|
BRKR
|
Bruker Corporation
|
1.18%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
1.16%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
1.04%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
1.01%
|
US
|
NASDAQ
|
|
UFPT
|
UFP Technologies, Inc.
|
0.97%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.93%
|
US
|
NASDAQ
|
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
0.78%
|
US
|
NASDAQ
|
|
PHR
|
Phreesia, Inc.
|
0.78%
|
US
|
NYSE
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.70%
|
US
|
NASDAQ
|